Skip to main content
ARGX logo

argenx SE

ARGXNASDAQHealthcareBiotechnology

$875.76Today:- (-)1Y +7.83%

As of Oct 22, 2026 close

Market cap
$56.51B
P/E (TTM)
25.35
Forward P/E
12.94
Dividend yield
-
52-week range
$661.85$1,072.75
Volume (live)
-
Avg. volume (3M)
426.02K

argenx SE (ARGX) Income Statement

argenx SE reported revenue of EUR 4.15B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 84.7% from EUR 2.25B a year earlier. Net income was EUR 1.29B, up 55.1% year over year, a net margin of 31.1%. Gross margin was 89.1% and operating margin 25.4%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $1.54B, up 59.3% from the same quarter a year earlier.

argenx SE Income Statement Analysis

Values in billions EUR

Scroll to see more
argenx SE income statement - Annual data in billions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue4.152.251.230.440.500.060.080.020.04
Cost of Revenue0.451.210.120.690.580.370.000.000.00
Gross Profit3.702.021.110.420.50-0.310.080.020.04
Operating Expenses
Research & Development1.360.980.860.660.580.370.220.100.06
Selling, General & Administrative1.361.060.710.470.310.170.070.030.01
Operating Expenses2.652.051.531.140.860.170.280.120.07
Operating Income1.05-0.02-0.43-0.72-0.36-0.48-0.20-0.09-0.03
Other Income/Expense
Interest Income0.160.160.090.030.000.010.010.000.00
Interest Expense0.000.000.000.000.000.000.000.000.00
Other Income/Expense0.220.110.12-0.01-0.040.000.020.02-0.01
Income
Income Before Tax1.280.09-0.30-0.73-0.40-0.61-0.18-0.08-0.03
Income Tax Expense-0.01-0.75-0.01-0.020.010.000.010.000.00
Net Income1.290.83-0.30-0.71-0.41-0.61-0.18-0.08-0.03
Net Income - Continuous Operations1.290.83-0.30-0.71-0.41-0.61-0.18-0.08-0.03
Net Income - Discontinued Operations---------
EBITDA1.31-0.02-0.19-0.62-0.39-0.48-0.17-0.09-0.03
EBIT1.05-0.02-0.42-0.72-0.40-0.48---
Depreciation & Amortization0.030.000.110.100.000.000.000.000.00
Earnings Per Share
Basic EPS21.0014.00-5.00-13.00-8.00-13.00-5.00-2.00-1.00
Diluted EPS20.0013.00-5.00-13.00-8.00-13.00-5.00-2.00-1.00
Basic Shares Outstanding0.060.060.060.050.050.050.040.040.02
Diluted Shares Outstanding0.070.070.060.050.050.050.040.040.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About argenx SE Financial Statements

What was argenx SE's revenue in fiscal 2025?

argenx SE reported revenue of EUR 4.15B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 84.7% from EUR 2.25B a year earlier.

Is argenx SE profitable?

Yes. argenx SE earned net income of EUR 1.29B in fiscal 2025, a net margin of 31.1%. In fiscal 2024 it earned EUR 833.04M.

What is argenx SE's operating margin?

argenx SE's operating income was EUR 1.05B on revenue of EUR 4.15B in fiscal 2025, an operating margin of 25.4%, compared with -1.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition